Search
for
Sort by
Research 631–660 of 1000+
- A Retrospective Analysis from Turkey: The Effect of the COVID-19 Outbreak Quarantine on Dermatology Outpatient Clinics
- AN SYNOPTIC OVERVIEW ON AUTOIMMUNE DISORDERS AND ITS MANAGEMENT
- Development and Invitro Evaluation of Solid Lipid Nano Particles Loaded Topical Gel Containing Combination of Drugs Used In The Better Therapy of Psoriasis
- Present Chemotherapy Induced Alopecia and Research in Future
- Retrospektive Analyse von Wirksamkeit, Sicherheit, prognostischen Parametern und Faktoren der Lebensqualität bei der topischen Immuntherapie der Alopecia areata mit Diphenylcyclopropenon
- Phytochemicals as emerging therapeutic agents for alopecia treatment
- Female hair loss
- Therapeutic Updates on Lichen planopilaris and Frontal Fibrosing Alopecia: A Systematic Review
- Frontal Fibrosing Alopecia
- Comparison of allogeneic stem cell transplant conditioning regimens in AML, MDS and CLL
- Follicular Neutrophilic Inflammation (Hidradenitis Suppurativa)
- British Hair and Nail Society
- Poster Abstracts
- Cutaneous Lupus Erythematosus
- Index
- Cutaneous Lupus Erythematosus
- Rely on clinical experience to help guide treatment selection for primary cicatricial (scarring) alopecias
- British Society for Dermatopathology
- Reporting on Adverse Clinical Events
- Impact of ustekinumab on quality of life and sexual difficulties associated with psoriasis: Results from phase III clinical trials
- Clinical Management in Psychodermatology
- Main Plenary Sessions: Summaries of Papers
- Cutaneous signals of immune system disease
- Skin and hair disorders
- Phytochemistry and Pharmacological Studies of Glycyrrhiza glabra: A Medicinal Plant Review
- JAK kinase pathway inhibitor drugs in patients with moderate-to-severe alopecia: a real-world experience
- Hair Loss in Children
- Postmenopausal Alopecia (Hair Loss)
- Alopecia cicatrizal como manifestación de lupus eritematoso cutáneo
- Topische Immuntherapie mit Diphenylcyclopropenon bei verschiedenen Typen der Alpecia areata: Assoziation zu klinischen Parametern und einem funktionellen Genpolymorphismus des Interleukin-6-Promotors